{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T12:04:47Z","timestamp":1789733087206,"version":"4.0.1"},"reference-count":52,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2012,6,28]],"date-time":"2012-06-28T00:00:00Z","timestamp":1340841600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Bone marrow mesenchymal stem cell-derived neural progenitors (MSC-NPs) are a potential therapeutic source of cells that have been shown to be efficacious in a preclinical model of multiple sclerosis (MS). To examine the feasibility of using MSC-NPs as an autologous source of cells to promote central nervous system (CNS) repair in MS, this study characterized human MSC-NPs from a panel of both MS and non-MS donors. Expanded MSCs showed similar characteristics in terms of growth and cell surface phenotype, regardless of the donor disease status. MSC-NPs derived from all MSCs showed a consistent pattern of gene expression changes that correlated with neural commitment and increased homogeneity. Furthermore, the reduced expression of mesodermal markers and reduced capacity for adipogenic or osteogenic differentiation in MSC-NPs compared with MSCs suggested that MSC-NPs have reduced potential of unwanted mesodermal differentiation upon CNS transplantation. The immunoregulatory function of MSC-NPs was similar to that of MSCs in their ability to suppress T-cell proliferation and to promote expansion of FoxP3-positive T regulatory cells in vitro. In addition, MSC-NPs promoted oligodendroglial differentiation from brain-derived neural stem cells that correlated with the secretion of bioactive factors. Our results provide a set of identity characteristics for autologous MSC-NPs and suggest that the in vitro immunoregulatory and trophic properties of these cells may have therapeutic value in the treatment of MS.<\/jats:p>","DOI":"10.5966\/sctm.2012-0015","type":"journal-article","created":{"date-parts":[[2012,6,30]],"date-time":"2012-06-30T00:13:03Z","timestamp":1341015183000},"page":"536-547","source":"Crossref","is-referenced-by-count":67,"title":["Characterization of Autologous Mesenchymal Stem Cell-Derived Neural Progenitors as a Feasible Source of Stem Cells for Central Nervous System Applications in Multiple Sclerosis"],"prefix":"10.1093","volume":"1","author":[{"given":"Violaine K.","family":"Harris","sequence":"first","affiliation":[{"name":"Multiple Sclerosis Research Center of New York, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raihan","family":"Faroqui","sequence":"additional","affiliation":[{"name":"Multiple Sclerosis Research Center of New York, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Vyshkina","sequence":"additional","affiliation":[{"name":"Multiple Sclerosis Research Center of New York, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saud A.","family":"Sadiq","sequence":"additional","affiliation":[{"name":"Multiple Sclerosis Research Center of New York, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2012,6,28]]},"reference":[{"key":"2021122705463871000_ref1","first-page":"941","volume-title":"Merritt's Neurology","author":"Sadiq","year":"2005","edition":"11th ed"},{"key":"2021122705463871000_ref2","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1146\/annurev-pathol-011110-130230","article-title":"Mesenchymal stem cells: Mechanisms of inflammation","volume":"6","author":"Singer","year":"2011","journal-title":"Annu Rev Pathol"},{"key":"2021122705463871000_ref3","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/glia.20841","article-title":"Human bone marrow-derived mesenchymal stem cells induce Th2-polarized immune response and promote endogenous repair in animal models of multiple sclerosis","volume":"57","author":"Bai","year":"2009","journal-title":"Glia"},{"key":"2021122705463871000_ref4","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1097\/NEN.0b013e3181f97392","article-title":"Human mesenchymal stem cells infiltrate the spinal cord, reduce demyelination, and localize to white matter lesions in experimental autoimmune encephalomyelitis","volume":"69","author":"Gordon","year":"2010","journal-title":"J Neuropathol Exp Neurol"},{"key":"2021122705463871000_ref5","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1001\/archneur.65.6.753","article-title":"Neuroprotection and immunomodulation with mesenchymal stem cells in chronic experimental autoimmune encephalomyelitis","volume":"65","author":"Kassis","year":"2008","journal-title":"Arch Neurol"},{"key":"2021122705463871000_ref6","doi-asserted-by":"crossref","first-page":"5994","DOI":"10.4049\/jimmunol.0803962","article-title":"Mesenchymal stromal cells ameliorate experimental autoimmune encephalomyelitis by inhibiting CD4 Th17 T cells in a CC chemokine ligand 2-dependent manner","volume":"182","author":"Rafei","year":"2009","journal-title":"J Immunol"},{"key":"2021122705463871000_ref7","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1182\/blood-2005-04-1496","article-title":"Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy","volume":"106","author":"Zappia","year":"2005","journal-title":"Blood"},{"key":"2021122705463871000_ref8","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1177\/1352458509359727","article-title":"The therapeutic potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: Consensus report of the international MSCT study group","volume":"16","author":"Freedman","year":"2010","journal-title":"Mult Scler"},{"key":"2021122705463871000_ref9","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nrneurol.2010.35","article-title":"Stem cell transplantation in multiple sclerosis: Current status and future prospects","volume":"6","author":"Martino","year":"2010","journal-title":"Nat Rev Neurol"},{"key":"2021122705463871000_ref10","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s12015-010-9173-y","article-title":"A consensus statement addressing mesenchymal stem cell transplantation for multiple sclerosis: It's time!","volume":"6","author":"Siatskas","year":"2010","journal-title":"Stem Cell Rev"},{"key":"2021122705463871000_ref11","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S1474-4422(11)70305-2","article-title":"Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: An open-label phase 2a proof-of-concept study","volume":"11","author":"Connick","year":"2012","journal-title":"Lancet Neurol"},{"key":"2021122705463871000_ref12","doi-asserted-by":"crossref","first-page":"4411","DOI":"10.1242\/jcs.01307","article-title":"Efficient generation of neural stem cell-like cells from adult human bone marrow stromal cells","volume":"117","author":"Hermann","year":"2004","journal-title":"J Cell Sci"},{"key":"2021122705463871000_ref13","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1126\/science.284.5411.143","article-title":"Multilineage potential of adult human mesenchymal stem cells","volume":"284","author":"Pittenger","year":"1999","journal-title":"Science"},{"key":"2021122705463871000_ref14","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1089\/scd.2008.0068","article-title":"Derivation of neural stem cells from mesenchymal stemcells: Evidence for a bipotential stem cell population","volume":"17","author":"Fu","year":"2008","journal-title":"Stem Cells Dev"},{"key":"2021122705463871000_ref15","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jns.2011.08.036","article-title":"Clinical and pathological effects of intrathecal injection of mesenchymal stem cell-derived neural progenitors in an experimental model of multiple sclerosis","volume":"313","author":"Harris","year":"2012","journal-title":"J Neurol Sci"},{"key":"2021122705463871000_ref16","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/j.exphem.2006.06.020","article-title":"Neural differentiation of human mesenchymal stem cells: Evidence for expression of neural markers and eag K+ channel types","volume":"34","author":"Mareschi","year":"2006","journal-title":"Exp Hematol"},{"key":"2021122705463871000_ref17","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1182\/blood-2006-12-063412","article-title":"Potential risks of bone marrow cell transplantation into infarcted hearts","volume":"110","author":"Breitbach","year":"2007","journal-title":"Blood"},{"key":"2021122705463871000_ref18","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.expneurol.2011.02.021","article-title":"Variable behavior and complications of autologous bone marrow mesenchymal stem cells transplanted in experimental autoimmune encephalomyelitis","volume":"230","author":"Grigoriadis","year":"2011","journal-title":"Exp Neurol"},{"key":"2021122705463871000_ref19","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"key":"2021122705463871000_ref20","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1177\/1352458510371959","article-title":"Characterization of in vitro expanded bone marrow-derived mesenchymal stem cells from patients with multiple sclerosis","volume":"16","author":"Mallam","year":"2010","journal-title":"Mult Scler"},{"key":"2021122705463871000_ref21","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jneuroim.2008.05.006","article-title":"Differences in mesenchymal stem cell cytokine profiles between MS patients and healthy donors: Implication for assessment of disease activity and treatment","volume":"199","author":"Mazzanti","year":"2008","journal-title":"J Neuroimmunol"},{"key":"2021122705463871000_ref22","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1002\/jnr.20840","article-title":"Comparative analysis of neuroectodermal differentiation capacity of human bone marrow stromal cells using various conversion protocols","volume":"83","author":"Hermann","year":"2006","journal-title":"J Neurosci Res"},{"key":"2021122705463871000_ref23","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1002\/stem.34","article-title":"Specific lineage-priming of bone marrow mesenchymal stem cells provides the molecular framework for their plasticity","volume":"27","author":"Delorme","year":"2009","journal-title":"Stem Cells"},{"key":"2021122705463871000_ref24","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.exphem.2007.11.007","article-title":"Mesenchymal cells recruit and regulate t regulatory cells","volume":"36","author":"Di Ianni","year":"2008","journal-title":"Exp Hematol"},{"key":"2021122705463871000_ref25","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1182\/blood.V99.10.3838","article-title":"Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli","volume":"99","author":"Di Nicola","year":"2002","journal-title":"Blood"},{"key":"2021122705463871000_ref26","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1365-2249.2009.03874.x","article-title":"Cell contact, prostaglandin E(2) and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25(high) forkhead box P3+ regulatory t cells","volume":"156","author":"English","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"2021122705463871000_ref27","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1517\/14712598.6.1.17","article-title":"Stem cells in inflammatory demyelinating disorders: A dual role for immunosuppression and neuroprotection","volume":"6","author":"Uccelli","year":"2006","journal-title":"Expert Opin Biol Ther"},{"key":"2021122705463871000_ref28","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s11064-006-9212-x","article-title":"Human mesenchymal stem cells signals regulate neural stem cell fate","volume":"32","author":"Bai","year":"2007","journal-title":"Neurochem Res"},{"key":"2021122705463871000_ref29","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1634\/stemcells.2005-0614","article-title":"Mesenchymal stem cells instruct oligodendrogenic fate decision on adult neural stem cells","volume":"24","author":"Rivera","year":"2006","journal-title":"Stem Cells"},{"key":"2021122705463871000_ref30","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1182\/blood-2007-02-069716","article-title":"Immunomodulatory properties of mesenchymal stromal cells","volume":"110","author":"Nauta","year":"2007","journal-title":"Blood"},{"key":"2021122705463871000_ref31","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1002\/jcb.20886","article-title":"Mesenchymal stem cells as trophic mediators","volume":"98","author":"Caplan","year":"2006","journal-title":"J Cell Biochem"},{"key":"2021122705463871000_ref32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0897.2011.01069.x","article-title":"Immunomodulatory properties of mesenchymal stem cells: Cytokines and factors","volume":"67","author":"Soleymaninejadian","year":"2012","journal-title":"Am J Reprod Immunol"},{"key":"2021122705463871000_ref33","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.bbrc.2007.07.052","article-title":"The role of IL-6 in inhibition of lymphocyte apoptosis by mesenchymal stem cells","volume":"361","author":"Xu","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"2021122705463871000_ref34","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.cellimm.2011.06.014","article-title":"Ligation of TLR2 and TLR4 on murine bone marrow-derived mesenchymal stem cells triggers differential effects on their immunosuppressive activity","volume":"271","author":"Lei","year":"2011","journal-title":"Cell Immunol"},{"key":"2021122705463871000_ref35","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1182\/blood-2006-06-028704","article-title":"Toll-like receptors and their ligands control mesenchymal stem cell functions","volume":"109","author":"Pevsner-Fischer","year":"2007","journal-title":"Blood"},{"key":"2021122705463871000_ref36","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.expneurol.2005.10.029","article-title":"Human mesenchymal stem cell subpopulations express a variety of neuro-regulatory molecules and promote neuronal cell survival and neuritogenesis","volume":"198","author":"Crigler","year":"2006","journal-title":"Exp Neurol"},{"key":"2021122705463871000_ref37","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.brainres.2006.07.127","article-title":"Adult mesenchymal stem cells rescue dorsal root ganglia neurons from dying","volume":"1116","author":"Scuteri","year":"2006","journal-title":"Brain Res"},{"key":"2021122705463871000_ref38","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.scr.2009.02.006","article-title":"Human bone marrow-derived mesenchymal stem cells secrete brain-derived neurotrophic factor which promotes neuronal survival in vitro","volume":"3","author":"Wilkins","year":"2009","journal-title":"Stem Cell Res"},{"key":"2021122705463871000_ref39","doi-asserted-by":"crossref","first-page":"10666","DOI":"10.1523\/JNEUROSCI.1944-11.2011","article-title":"Vascular endothelial growth factor regulates the migration of oligodendrocyte precursor cells","volume":"31","author":"Hayakawa","year":"2011","journal-title":"J Neurosci"},{"key":"2021122705463871000_ref40","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1097\/01.wnr.0000227985.92551.9a","article-title":"Modulation of rat oligodendrocyte precursor cells by the chemokine CXCL12","volume":"17","author":"Maysami","year":"2006","journal-title":"Neuroreport"},{"key":"2021122705463871000_ref41","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1750-3639.1996.tb00858.x","article-title":"Regulation of oligodendrocyte development and CNS myelination by growth factors: Prospects for therapy of demyelinating disease","volume":"6","author":"McMorris","year":"1996","journal-title":"Brain Pathol"},{"key":"2021122705463871000_ref42","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/jnr.10323","article-title":"Hepatocyte growth factor stimulates the proliferation and migration of oligodendrocyte precursor cells","volume":"69","author":"Yan","year":"2002","journal-title":"J Neurosci Res"},{"key":"2021122705463871000_ref43","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1002\/stem.312","article-title":"In vitro high-capacity assay to quantify the clonal heterogeneity in trilineage potential of mesenchymal stem cells reveals a complex hierarchy of lineage commitment","volume":"28","author":"Russell","year":"2010","journal-title":"Stem Cells"},{"key":"2021122705463871000_ref44","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1001\/archneurol.2010.248","article-title":"Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis","volume":"67","author":"Karussis","year":"2010","journal-title":"Arch Neurol"},{"key":"2021122705463871000_ref45","first-page":"50","article-title":"Does mesenchymal stem cell therapy help multiple sclerosis patients? Report of a pilot study","volume":"4","author":"Mohyeddin Bonab","year":"2007","journal-title":"Iran J Immunol"},{"key":"2021122705463871000_ref46","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jneuroim.2010.07.013","article-title":"Bone marrow mesenchymal stem cell transplantation in patients with multiple sclerosis: A pilot study","volume":"227","author":"Yamout","year":"2010","journal-title":"J Neuroimmunol"},{"key":"2021122705463871000_ref47","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.expneurol.2011.03.012","article-title":"The risk of putting something where it does not belong: Mesenchymal stem cells produce masses in the brain","volume":"230","author":"Snyder","year":"2011","journal-title":"Exp Neurol"},{"key":"2021122705463871000_ref48","doi-asserted-by":"crossref","first-page":"9142","DOI":"10.1158\/0008-5472.CAN-06-4690","article-title":"Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms","volume":"67","author":"Bernardo","year":"2007","journal-title":"Cancer Res"},{"key":"2021122705463871000_ref49","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1158\/0008-5472.CAN-04-4194","article-title":"Spontaneous human adult stem cell transformation","volume":"65","author":"Rubio","year":"2005","journal-title":"Cancer Res"},{"key":"2021122705463871000_ref50","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.cellbi.2006.11.025","article-title":"Cytogenetic analysis of human bone marrow-derived mesenchymal stem cells passaged in vitro","volume":"31","author":"Zhang","year":"2007","journal-title":"Cell Biol Int"},{"key":"2021122705463871000_ref51","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.stem.2011.06.013","article-title":"Large-scale analysis reveals acquisition of lineage-specific chromosomal aberrations in human adult stem cells","volume":"9","author":"Ben-David","year":"2011","journal-title":"Cell Stem Cell"},{"key":"2021122705463871000_ref52","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1582-4934.2011.01303.x","article-title":"Chromosomal variability of human mesenchymal stem cells cultured under hypoxic conditions","volume":"16","author":"Ueyama","year":"2012","journal-title":"J Cell Mol Med"}],"container-title":["Stem Cells Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.5966%2Fsctm.2012-0015","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.5966%2Fsctm.2012-0015","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/stcltm\/article-pdf\/1\/7\/536\/41882446\/stcltm_1_7_536.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/stcltm\/article-pdf\/1\/7\/536\/41882446\/stcltm_1_7_536.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T02:46:32Z","timestamp":1642560392000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/stcltm\/article\/1\/7\/536-547\/6385265"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,28]]},"references-count":52,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2012,6,28]]},"published-print":{"date-parts":[[2012,7,1]]}},"URL":"https:\/\/doi.org\/10.5966\/sctm.2012-0015","relation":{},"ISSN":["2157-6564","2157-6580"],"issn-type":[{"value":"2157-6564","type":"print"},{"value":"2157-6580","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2012,7,1]]},"published":{"date-parts":[[2012,6,28]]}}}